Category: BIORISE
7 New Ideas to Start a Healthcare Business in India (2018)
Seven new #healthcare #business ideas in India in 2018. Which one would you prefer to pursue?
It’s not only about Nipah Virus in Kerala!!!
This disease is not new in India but has revisited for the third time after previously outbreaking in the two districts of West Bengal – Siliguri and Nadia in 2001 and 2007 respectively. High fatality rate (about 70 percent) and easy person-to-person transmission of the disease had already been established during its previous encounters but still, there is no vaccine for the prevention or cure of the disease and only supportive treatment is given for the disease-related complications including neurological and respiratory complications.
This Cancer Biotech Startup Raises Over 40% Higher in IPO than Proposed Goal
The cancer startup develops novel immunotherapies that target the immune-suppressive tumor microenvironment to attack cancer. The company is developing immuno-oncology drugs which could be combined with existing immunotherapies to enhance the efficiency of detecting and killing cancer cells.
AI-Based Pharma Startup BenevolentAI worth $2 Billion Raises $115 M Funding
UK-based BenevolentAI raised one of the largest fundings in AI pharmaceutical field. The company is significantly disrupting the pharma industry which spends $180 billion in a year on R&D.
Genprex Raises $6.4 M in IPO, Could Bring “Game-Changing” Immuno-Gene Therapy for Advanced Lung Cancer
Genprex raised $6.4 million in IPO at a share price of $5. Unlike most of the commercial blockbuster lung cancer immunotherapies, its unique lead candidate, Oncoprex® targets advanced lung cancer treatment.
Delhi-Based Healthcare Fintech Startup Raises $1 M in Seed Funding Round
Delhi-based healthcare financing startup, LetsMD has raised $1 million a pre-series A funding round led by SRI Capital.
AI–Based Nutrition Analytics Startup, Nutrino Raises $8 M in Series A Funding
Israeli startup Nutrino raised $8 million in their Series A funding round led by the existing investor New York Angels. According to the Medgenera report, the investment funding in health analytics is estimated to reach around $4.4 billion in 2018 at about 65.7% CAGR during 2015-2018.
Pharma Patents: Can India Reward Incremental Innovation?
Chandramouli Natarajan is an Associate Scientist, Ricon pharma LLC, Denville, USA. He has presented his opinion and views on the Pharmaceutical patents issues in India. This article is available for free to read and share.
First Japanese Company Shionogi Receives CARB-X Funding for New Antibiotics Development against Superbugs
KEY POINTS CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) founded by US government Agencies and Wellcome Trust, London funds companies to ...
Infographics: Health-Tech Startup HealthAssure Raises $1 M from The HR Fund
Illustration: Bigstockphoto